Data as of May 20
| +0.005 / +0.76%|
The 2 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +278.79% increase from the last price of 0.66.
The current consensus among 2 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.